Search Results

You searched for : GlaxoSmithKline  

Unveiling the Menace of Counterfeit Medicines: Telangana Seizes Fake Drugs Worth Rs 33.3 Lakhs

By working together to address this grave threat, we can uphold the integrity of the pharmaceutical industry and protect the health and safety of individuals ...
Mar 07

India’s first indigenously developed vaccine against cervical cancer will hit the market soon

India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ...
Sep 02

Cancer cure now possible? Major breakthrough Treatment with Dostarlimab

A cancer patient has new hope for a cancer cure now. Let us look into details to beat cancer with the new drug Dostarlimab. ...
Jun 09

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update...
Aug 02

GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with anaemia

GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (...
Jul 17

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ...
Jun 22

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG....
Jun 14

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

GSK's Covid product could be soon in the market after the emergency medical application review...
May 11

FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker

GSK gets FDA nod for Jemperli indicated for endometrial cancer...
Apr 26

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK

The agreement is for the advancement of multiple pre-phase 2 programs...
Mar 22

Sanofi's mRNA vaccine would not be available this year ; CEO

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO ...
Feb 15

GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers Symposium

GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ...
Jan 18

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19

Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ...
Jan 12

Sosei Heptares collaborates with GlaxoSmithKline targeting immune disorders of the digestive system

GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform...
Dec 22

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US

BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ...
Dec 18

Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalized adults with COVID-19

ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19....
Dec 18

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left....
Dec 11

Conflicts of interest among the UK government’s covid-19 advisers are not transparent

The BMJ’s attempts to discover more have been thwarted ...
Dec 11

US FDA accepts GSK’s filing of Nucala for use in chronic rhinosinusitis with nasal polyps

If approved, Nucala would be the only treatment approved in the US for use in four eosinophil-driven diseases. ...
Dec 08

GSK starts phase 3 study of RSV maternal candidate vaccine

Currently no vaccine is available for respiratory syncytial virus...
Nov 23

25 Matching result(s) found!

-Advertisements-




Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024